Medical Developments International Ltd (ASX:MVP)
A$ 0.42 0.01 (2.44%) Market Cap: 46.19 Mil Enterprise Value: 38.74 Mil PE Ratio: 0 PB Ratio: 0.81 GF Score: 57/100

Half Year 2022 Medical Developments International Ltd Earnings Call Transcript

Feb 24, 2022 / 11:00PM GMT
Release Date Price: A$3.46 (-0.28%)
Gordon Naylor
Medical Developments International Limited - Chairman

Okay. So good morning, everyone, and welcome to the investor briefing for Medical Developments International's half-year result. So as you're aware, the company did release the results yesterday afternoon, and this is an opportunity for us to add a little bit more color to those results.

So my name is Gordon Naylor. I'm the company Chair; and I'm joined by Brent MacGregor, the company Chief Executive Officer. So I'll make a couple of introductory comments and then pass to Brent. Just on housekeeping, the presentation is being recorded for those investors who are unable to join the live call this morning.

So just by way of introduction, although trading conditions have continued to be challenging and the sale numbers are off a low base, I do think that MVP has had an impressive half year. Brent will take you through the detail. But sales growth has been strong across all our primary franchises, especially notable in our core European Penthrox growth corridor despite the heavy COVID measures taken during the European

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot